News
11.01.2022 We are starting the new year with good news! TRACE study initiated its third clinical site in France. Hôpital universitaire Robert-Debré in Paris (FR) will be ready to recruit patients very soon.
23.11.2021 Today we held our Annual Meeting with the TRACE Consortium. Due to the ongoing COVID-19 pandemic, this year's meeting was an online meeting, once again. Despite these circumstances, important topics could be discussed and lively discussions took place.
We would like to thank the TRACE Consortium for a successful year 2021 and are looking forward to the next year!
03.11.2021 The second site in France is open and ready to recruit patients at University Hospital in Lille, Centre Hospitalier Universitaire, CHU de Lille (FR).
26.10.2021 Another clinical site in Germany joined TRACE and is active and open for recruitment at University Children's Hospital in Essen, Klinik für Kinderheilkunde III, UK Essen (DE).
15.10.2021 We are pleased to announce that there is one more clinical site in Germany active and open for recruitment at University Hospital in Dresden, Technische Universität Dresden (DE).
24.08.2021 We would like to announce that Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology at University Hospital Leipzig (DE) joined our study.
17.08.2021 We are happy to welcome an additional initiated site in Belgium at University Hospital in Leuven, Universitaire Ziekenhuizen, UZ Leuven (BE).
10.08.2021 We are happy to announce that our study is now open for recruitment in Italy and France. Patients can therefore be enrolled into TRACE study in five European countries:
Germany, Netherlands, Belgium, Italy and France.
19.07.2021 TRACE study was initiated in Italy. The first initiation was performed at our Consortium partner from L'Ospedale Pediatrico Bambino Gesù in Rome (IT).
12.07.2021 Another clinical site is active and open for recruitment in Belgium at the University Hospital in Brussels, Universitair Ziekenhuis, UZ Brussel (BE).
05.07.2021 The first initiation of TRACE was performed in France. Welcome to our Consortium partner from Nancy University Hospital, CHRU de Nancy (FR).
24.06.2021 Another site in Germany is active and open for recruitment at Hannover Medical School, MHH (DE).
17.06.2021 The Consortium partner from Ghent Universal Hospital, UZG (BE) has been activated for the study. The clinical site is initiated and open for patient recruitment and the manufacturing site is ready for production of T-cell products.
08.06.2021 We welcome Institut Jules Bordet in Brussels (BE) to our study, which is now open for recruitment in Belgium.
17.05.2021 Growing number of sites: another site in Germany was initiated at University Children's Hospital Tübingen (DE).
10.05.2021 We gladly announce that our study is now open for recruitment in a third country, Belgium. The first site that was initated here is Centre Hospitalier Universitaire (CHU) de Liège (BE).
03.05.2021 We are happy to announce that we opened another site
in Germany at Universitätsklinikum Würzburg (DE)
14.04.2021 We are expanding our team and are looking for a
Study Nurse/Dokumentar (m/w/d) for the site in Munich
Send your application to: kinderkrebszentrum@med.uni-muenchen.de
Find more information here.
07.04.2021 We are happy to welcome an additional initiated site
LMU Klinikum München, Med. Klinik III (DE)
18.12.2020 Growing numbers of active sites:
Leiden University Medical Centre (NL)
Charité Berlin (DE)
Klinikum rechts der Isar - Technische Universität München (DE)
Universitätsklinikum Düsseldorf (DE)
LMU Klinikum München, Dr. von Hauner Children`s Hospital (DE)
12.11.2020 Virtual Annual Meeting
28.10.2020 We are expanding our Team
Study Coordinator (m/f/d) Site Munich
Send us your application: kinderkrebszentrum@med.uni-muenchen.de
Find more information here
04.08.2020 5 CA approvals completed:
the Netherlands, France, Belgium, Italy and Germany
20.09.- 21.09.2019 Annual Meeting
Rome, ITALY
01.02.-02.02.2018 Kick-off Meeting
Eibsee, GERMANY
